- 81
- 7 180
Fondazione Italiana Fegato - FIF ONLUS
Italy
เข้าร่วมเมื่อ 20 ม.ค. 2021
Canale di youtube della Fondazione Italiana Fegato.
Fondata nel 2008 da un’idea illuminata del Prof. Claudio Tiribelli, professore di Gastroenterologia all’Università di Trieste e luminare nel campo dell’epatologia, la Fondazione Italiana Fegato (FIF) è un ente di ricerca riconosciuto dal MIUR specializzato nello studio sulle malattie epatiche e patologie correlate.
Nella sua attività scientifica, la FIF collabora con diverse organizzazioni a livello internazionale, dal Messico all’Indonesia, dall’Argentina agli Stati Uniti. Con tali paesi la FIF mantiene una collaborazione attiva e un continuo scambio di giovani ricercatori, scienziati, dottorandi che arrivano alla Fondazione per incrementare la loro esperienza e condividere con noi le loro competenze.
Fondata nel 2008 da un’idea illuminata del Prof. Claudio Tiribelli, professore di Gastroenterologia all’Università di Trieste e luminare nel campo dell’epatologia, la Fondazione Italiana Fegato (FIF) è un ente di ricerca riconosciuto dal MIUR specializzato nello studio sulle malattie epatiche e patologie correlate.
Nella sua attività scientifica, la FIF collabora con diverse organizzazioni a livello internazionale, dal Messico all’Indonesia, dall’Argentina agli Stati Uniti. Con tali paesi la FIF mantiene una collaborazione attiva e un continuo scambio di giovani ricercatori, scienziati, dottorandi che arrivano alla Fondazione per incrementare la loro esperienza e condividere con noi le loro competenze.
YW2024: “Alcohol and the New Nomenclature of Steatotic Liver Disease” by Prof. Aleksander Krag
Aleksander Krag, MD, PhD, MBA
Secretary General, EASLD
Director, Centre for Liver Research, Odense University Hospital
DIAS Chair of Health Sciences, University of Southern Denmark
Department Chair, Department of Gastroenterology and Hepatology
Odense University Hospital
Title: “Alcohol and the New Nomenclature of Steatotic Liver Disease”
===============================================================
FOLLOW US:
LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/
Instagram - fondazioneitalianafegato
Facebook - it-it. fondazioneitalianafegato/
TH-cam: www.youtube.com/@fondazioneitalianafegato
Twitter: FondItaFegato
web: www.fegato.it
#FIFonlus #yellowebinar #liver #oneliver #loveyourliver
Secretary General, EASLD
Director, Centre for Liver Research, Odense University Hospital
DIAS Chair of Health Sciences, University of Southern Denmark
Department Chair, Department of Gastroenterology and Hepatology
Odense University Hospital
Title: “Alcohol and the New Nomenclature of Steatotic Liver Disease”
===============================================================
FOLLOW US:
LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/
Instagram - fondazioneitalianafegato
Facebook - it-it. fondazioneitalianafegato/
TH-cam: www.youtube.com/@fondazioneitalianafegato
Twitter: FondItaFegato
web: www.fegato.it
#FIFonlus #yellowebinar #liver #oneliver #loveyourliver
มุมมอง: 47
วีดีโอ
YW2024: "Notch Signaling in Liver Cancer" by Dr. Laura Gragnani
มุมมอง 27หลายเดือนก่อน
Laura Gragnani, PhD Medical School Department of Translational Research & NTMS University of Pisa, Italy Title: "Notch Signaling in Liver Cancer" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ TH-cam: www.youtube.com/@fondazioneitalianafegato Twitter: twitter.com...
YW2024: "Tissue-derived Organoid Models and their Biomedical Applications" by Dr. Meritxell Huch
มุมมอง 42หลายเดือนก่อน
Meritxell Huch, PhD Director Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) Lise Meitner Excellence Program, Max Planck Society Dresden, Germany Title "Tissue derived organoid models and their biomedical applications" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. f...
Servizio TRC Modena - 3 Novembre 2024
มุมมอง 20หลายเดือนก่อน
Su TRC Modena si parla della nuova collaborazione sullo studio benefici dell'olio extravergine di oliva realizzata con Coop Alleanza 3.0 Quanto sappiamo sull'Olio EVO? 🫒🥣 Anche se ci sono già studi promettenti, la ricerca non si ferma! Aiutaci a sostenere il nostro progetto di ricerca Progetto O-liver www.paypal.com/donate/?campaign_id=2P7VJCP6F95L6 #olioevo #salute #fundraising #olioextravergi...
YW2024: "Circulating Biomarkers of Response to Systemic Treatments in Advanced HCC" -Claudia Campani
มุมมอง 503 หลายเดือนก่อน
Claudia Campani, MD PhD Department of Experimental and Clinical Medicine, Internal Medicine and Hepatology Unit, University of Firenze, Florence, Italy Cordeliers Research Center, Sorbonne University, Inserm Paris Cité University, "Functional Genomics of Solid Tumors" team Ligue Nationale Contre le Cancer accredited team Labex OncoImmunology, Paris, France Title: "Circulating biomarkers of resp...
YW2024: "How to choose a murine model that best recapitulates human MASLD?" by Dr. Michele Vacca
มุมมอง 523 หลายเดือนก่อน
Michele Vacca MD PhD Associate Professor Interdisciplinary Department of Medicine, Università degli Studi di Bari Aldo Moro, Bari - Italy Principal Investigator, “Hepatic Metabolism and MASLD” Lab The Roger Williams Institute of Hepatology Foundation for Liver Research London, UK TITLE "How to choose a murine model that best recapitulates human MASLD? An unbiased ranking based on proximity to h...
YW2024: "Compensated Advanced Chronic Liver Disease: Baveno VII Consensus and Beyond" Dr. Berzigotti
มุมมอง 1453 หลายเดือนก่อน
Annalisa Berzigotti MD PhD Head of Hepatology and Clinic Director ad Interim, University Clinic for Visceral Surgery and Medicine (UVCM), Inselspital, University Hospital of Bern; Associate Professor of Hepatology, University of Bern; Research group leader, DBMR Title: "Compensated Advanced Chronic Liver Disease: Baveno VII Consensus and Beyond" FOLLOW US: LinkedIn - www.linkedin.com/company/fo...
La Fondazione Italiana Fegato eccellenza da sostenere.Il Governatore Fedriga alla FIF (video FVG.TV)
มุมมอง 545 หลายเดือนก่อน
📣"La Fondazione italiana fegato è un'eccellenza del Friuli Venezia Giulia che, nel tempo, ha saputo stringere collaborazioni a livello globale e realizzare importanti progetti internazionali. Un'intensa attività che ha arricchito il nostro sistema di salute, grazie a iniziative di ricerca, formazione ed educazione rivolte a tutte le fasce della popolazione" ➡️Lo ha affermato il governatore dell...
YW2024: "Lean MASLD: Facts or Function?" by Prof. Elisabetta Bugianesi
มุมมอง 2515 หลายเดือนก่อน
Elisabetta Bugianesi Full Professor in Gastroenterology Scientific Director and Deputy Director Department of Medical Sciences University of Torino, Italy Title: "Lean MASLD: Facts or Function?" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ TH-cam: www.youtube.c...
YW2024: "Biomarkers for Risk Stratification and Chemoprevention of HCC" by Prof. Yujin Hoshida
มุมมอง 765 หลายเดือนก่อน
Prof. Yujin Hoshida Director, Liver Tumor Translational Research Program University of Texas, Southwestern Medical Center Dallas TITLE: "Biomarkers for risk stratification and chemoprevention of hepatocellular carcinoma" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafeg...
YW2024: "Mythbusters: NAFLD or MASLD or DAFLD?" by Prof. Robert Lustig
มุมมอง 3.3K5 หลายเดือนก่อน
Robert Lustig, MD, MSL Emeritus Professor in Pediatrics, Division of Endocrinology, University of California, San Francisco (UCSF) Member, Institute for Health Policy Studies, UCSF TITLE: "Mythbusters: NAFLD or MASLD or DAFLD?" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneital...
YW2024: "Visualising & Understanding Neural Plasticity in Pancreatic Cancer Development" -Fanny Mann
มุมมอง 515 หลายเดือนก่อน
Fanny Mann The Marseille Developmental Biology Institute (IBDM), France TITLE: "Visualising and understanding neural plasticity in pancreatic cancer development" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ TH-cam: www.youtube.com/@fondazioneitalianafegato Twit...
YW2024: "Hepatokines in MAFLD: from Bench to Clinic" by Prof. Aimin Xu
มุมมอง 865 หลายเดือนก่อน
Prof. Aimin Xu Chair, Professor Department of Pharmacology and Pharmacy, The University of Hong Kong TITLE: "Hepatokines in MAFLD: from bench to clinic" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ TH-cam: www.youtube.com/@fondazioneitalianafegato Twitter: twit...
YW2024: "Juvenile Autoimmune Liver Disease" by Prof. Giorgina Mieli-Vergani
มุมมอง 345 หลายเดือนก่อน
Giorgina Mieli-Vergani Professor of Paediatric Hepatology King's College London School of Medicine Title: "Juvenile Autoimmune Liver Disease" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ TH-cam: www.youtube.com/@fondazioneitalianafegato Twitter: Fon...
YW2024: "Severe neonatal hyperbilirubinemia and Crigler-Najjarr syndrome" by Andres Muro
มุมมอง 195 หลายเดือนก่อน
Andrés Muro Principal Investigator, Group Leader, ICGEB (International Centre for Genetic Engineering and Biotechnology) Trieste, Italy Title: "Severe neonatal hyperbilirubinemia and Crigler-Najjarr syndrome: lessons from studies with animal models and patients" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook ...
YW2024: "Unveiling opportunities for precision therapeutics in liver cancer through..." -Carmen Wong
มุมมอง 7810 หลายเดือนก่อน
YW2024: "Unveiling opportunities for precision therapeutics in liver cancer through..." -Carmen Wong
YW2024: "Hepatitis D: New Developments" by Mario Rizzetto
มุมมอง 4910 หลายเดือนก่อน
YW2024: "Hepatitis D: New Developments" by Mario Rizzetto
YW2023: "RNA Therapies in Age-Related Disorders" - Dr. Fabrizio d'Adda di Fagagna
มุมมอง 63ปีที่แล้ว
YW2023: "RNA Therapies in Age-Related Disorders" - Dr. Fabrizio d'Adda di Fagagna
YW2023: "Chromatin, Alternative Splicing and The Cure of An Hereditary Disease" - Dr. Kornblihtt
มุมมอง 35ปีที่แล้ว
YW2023: "Chromatin, Alternative Splicing and The Cure of An Hereditary Disease" - Dr. Kornblihtt
YW2023: "Immunotherapy for HCC: Challenges in Clinical Practice"
มุมมอง 14ปีที่แล้ว
YW2023: "Immunotherapy for HCC: Challenges in Clinical Practice"
YW2023: "Bariatric Surgery as Potential Treatment for NAFLD"
มุมมอง 20ปีที่แล้ว
YW2023: "Bariatric Surgery as Potential Treatment for NAFLD"
YW2023: "The Role of Bile Acids in Fatty Liver" - Dr. Rohit Kohli
มุมมอง 86ปีที่แล้ว
YW2023: "The Role of Bile Acids in Fatty Liver" - Dr. Rohit Kohli
YW2023: ‘’Immunotherapy Combinations for Advanced HCC‘’ - Lorenza Rimassa, MD
มุมมอง 68ปีที่แล้ว
YW2023: ‘’Immunotherapy Combinations for Advanced HCC‘’ - Lorenza Rimassa, MD
YW2023: ‘’Immunomodulatory Strategies for ALD: Why, How and When?‘’ - Dr. Antonio Riva
มุมมอง 16ปีที่แล้ว
YW2023: ‘’Immunomodulatory Strategies for ALD: Why, How and When?‘’ - Dr. Antonio Riva
YW2023: "Crosstalk between RNA Processing and DNA Repair in Cancer Development" - Dr. Gianluca Tell
มุมมอง 6ปีที่แล้ว
YW2023: "Crosstalk between RNA Processing and DNA Repair in Cancer Development" - Dr. Gianluca Tell
YW2023: "Food and Exercise as Medicine: Metabolic and Molecular Effects" - Dr. Luigi Fontana
มุมมอง 209ปีที่แล้ว
YW2023: "Food and Exercise as Medicine: Metabolic and Molecular Effects" - Dr. Luigi Fontana
YW2023: "Tale of Two Projects: from Genetic Screening Cancer to Data Science" - Mario Rossi
มุมมอง 23ปีที่แล้ว
YW2023: "Tale of Two Projects: from Genetic Screening Cancer to Data Science" - Mario Rossi
YW2023: "SteatoSITE: A Gene-to-Outcome Data Commons for NAFLD Research"
มุมมอง 27ปีที่แล้ว
YW2023: "SteatoSITE: A Gene-to-Outcome Data Commons for NAFLD Research"
YW2023: "Interdisciplinary Management of Fatty Liver Disease" - Dr. Jeffrey Lazarus
มุมมอง 10ปีที่แล้ว
YW2023: "Interdisciplinary Management of Fatty Liver Disease" - Dr. Jeffrey Lazarus
YW2023: "...Tumour Immune Microenvironment for Biomarker & Therapeutic Discovery in HCC" - Dr. Chew
มุมมอง 27ปีที่แล้ว
YW2023: "...Tumour Immune Microenvironment for Biomarker & Therapeutic Discovery in HCC" - Dr. Chew
Well done Noel, we miss you!
What an excellent presentation, it really opens so many possibilities for the understanding of chronic disease. Thank you
I am very very disappointed. once, some 5 or 6 y ago, Dr. Lustig made me awae about the sugar problem. But here, this presentation is just awful. he tries to whitewash being fat by constructing a paper tiger and engaging wrong arguments. At mark @7.00 you can observe how a statistics is getting constructed and abused : first you focus on an arbitrary threshold, in this case "obesity is BMI of 30+", then define the opposite as "nomal", and next you present the conundrum that in normal weight people obesity rises. At @8:28 he even starts to call people with a BMI of 30 "thin". ...holy crap.... Sorry, since when is a BMI between 25 and 30 normal weight? It is even medically rated as "overweight". By any means "normal" would be for BMI<25, as coarse and misleading that is. A child with 24 is NOT normal, becaus much lower portion of lean mass, wheeas an adult male with BMI 26 coud be normal. BMI is outdated. ...which just adds to the invalidity of the argument. Its complete BS. Just exaggarated at 11:00+ when he cites a study about a small population with missing HGH receptors and draws conclusions for the gneral popuplation... that's intellectual dishonesty to its purest. At 16:20 then he claims that, quote, "visceral fat is a consequence of chronic stress, not of diet." ...that's just becoming criminal... A bad mistake at 29:00. He showing a slide about effects of glucose and fructose ono the capablity of the liver to process fat. Frucose is bad, yes, but there is absolutely NO indication that glucose improve beta-oxidation, also from other studies. It also disrgards what s calle energy toxicity. Agan, BS, here va cherry picking. Bad mistake at 41:38 ... caling, qute, "methionine the second rarest amino acid in the diet"... very wrong, indeed. I do not kow o which diet he is referring to here, but diet tracking via cronometer, which uses public US dietary databases, is showing me daily quite the opposite. And btw, talking about "the diet" is quite an overgeneralisation. The part about fructose is ok, but fructose is from diet. Fatty liver, even in the beginning, directly spills over into visceral fat, which is inflammatory. Whether you eat a lot of fructose anfd 500 kcal too much every day or just 2000kcal per day too much of a "healthy" diet does not matter. Both make you fat and sick. And of course, hypertroph fat cells spill free FA like hell, making you sick. Obesity or too much fat is indeed making sick in 95% of all cases. Better to temove ths video, it is just bad
Excellent upload. Next, try interviewing Tim Noakes. Thank you.
An excellent podcast and all congrats to the host which didn't interrupt professor Lustig with personal questions as all these long-nails ladies and big muscles folks are doing around. Keep delivering humanity clear and clean information, waiting for other podcasts with Dr Bickman, Dr RickJohnson and other great health modern miners
Thank you for uploading
you need to give titles to the videos that make sense. this way noone knows what the videos are about and are also not searchable.
Greetings! Thank you very much for your feedback, we will incorporate your valuable suggestion in our current and future videos.